Relationship between GII.3 norovirus infections and blood group antigens in young children in Tunisia

Clinical Microbiology and Infection

Volumn 21, Issue 9, 2015, Pages 874.e1-874.e8

  Ayouni, S ^a,b   Estienney, M ^a   Sdiri Loulizi, K ^b   Ambert Balay, K ^a   de Rougemont, A ^a   Aho, S ^a   Hammami, S ^c   Aouni, M ^b   Guediche M N ^c   Pothier, P ^a   Belliot, G ^a  

^a Public Hospital of Dijon   (France)

^b UNIVERSITY OF MONASTIR   (Tunisia)

^c FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

Children; Gastroenteritis; HBGA; Infection; Norovirus; Receptor

Indexed keywords

BLOOD GROUP ABH ANTIGEN; BLOOD GROUP ANTIGEN; FUCOSYLTRANSFERASE; FUCOSYLTRANSFERASE TYPE 2; UNCLASSIFIED DRUG;

ACUTE GASTROENTERITIS; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; BLOOD GROUP ABO SYSTEM; BLOOD GROUP LEWIS SYSTEM; BLOOD SAMPLING; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; DEHYDRATION; DIARRHEA; DNA EXTRACTION; FECES ANALYSIS; FEVER; GENOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN; NOROVIRUS INFECTION; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVA ANALYSIS; TUNISIA; VIRUS ATTACHMENT; VIRUS DETECTION; VIRUS ISOLATION; VIRUS LIKE AGENT; VIRUS STRAIN; VOMITING; WINTER; CALICIVIRIDAE INFECTIONS; CLASSIFICATION; GASTROENTERITIS; GENETICS; HOSPITAL; ISOLATION AND PURIFICATION; NOROVIRUS; VIROLOGY;

NOROVIRUS;

BLOOD GROUP ANTIGENS; CALICIVIRIDAE INFECTIONS; CHILD, PRESCHOOL; GASTROENTERITIS; GENOTYPE; HOSPITALS; HUMANS; INFANT; NOROVIRUS; TUNISIA; VIRUS ATTACHMENT;

EID: 84940614620     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2015.05.015     Document Type: Article

References (40)

1. Zheng D.P., Ando T., Fankhauser R.L., Beard R.S., Glass R.I., Monroe S.S. Norovirus classification and proposed strain nomenclature. Virology 2006, 346(2):312-323.
2. Eden J.S., Hewitt J., Lim K.L., Boni M.F., Merif J., Greening G., et al. The emergence and evolution of the novel epidemic norovirus GII.4 variant Sydney 2012. Virology 2014, 450-451:106-113.
3. Bull R.A., White P.A. Mechanisms of GII.4 norovirus evolution. Trends Microbiol 2011, 19(5):233-240.
4. Marionneau S., Ruvoën N., Le Moullac-Vaidye B., Clement M., Cailleau-Thomas A., Ruiz-Palacois G., et al. Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology 2002, 122(7):1967-1977.
5. Marionneau S., Cailleau-Thomas A., Rocher J., Le Moullac-Vaidye B., Ruvoen N., Clement M., et al. ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world. Biochimie 2001, 83(7):565-573.
6. Grahn A., Elmgren A., Aberg L., Svensson L., Jansson P.A., Lonnroth P., et al. Determination of Lewis FUT3 gene mutations by PCR using sequence-specific primers enables efficient genotyping of clinical samples. Hum Mutat 2001, 18(4):358-359.
7. Soejima M., Munkhtulga L., Iwamoto S., Koda Y. Genetic variation of FUT3 in Ghanaians, Caucasians, and Mongolians. Transfusion 2009, 49(5):959-966.
8. Cakir B., Pankow J.S., Salomaa V., Couper D., Morris T.L., Brantley K.R., et al. Distribution of Lewis (FUT3) genotype and allele: frequencies in a biethnic United States population. Ann Hematol 2002, 81(10):558-565.
9. Lindesmith L., Moe C., Marionneau S., Ruvoen N., Jiang X., Lindblad L., et al. Human susceptibility and resistance to Norwalk virus infection. Nat Med 2003, 9(5):548-553.
10. Cao S., Lou Z., Tan M., Chen Y., Liu Y., Zhang Z., et al. Structural basis for the recognition of blood group trisaccharides by norovirus. JVirol 2007, 81(11):5949-5957.
11. Choi J.M., Hutson A.M., Estes M.K., Prasad B.V. Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus. Proc Natl Acad Sci USA 2008, 105(27):9175-9180.
12. Nordgren J., Nitiema L.W., Ouermi D., Simpore J., Svensson L. Host genetic factors affect susceptibility to norovirus infections in Burkina Faso. PLoS ONE 2013, 8(7):e69557.
13. Jin M., He Y., Li H., Huang P., Zhong W., Yang H., et al. Two gastroenteritis outbreaks caused by GII noroviruses: host susceptibility and HBGA phenotypes. PLoS ONE 2013, 8(3):e58605.
14. Thorven M., Grahn A., Hedlund K.O., Johansson H., Wahlfrid C., Larson G., et al. Ahomozygous nonsense mutation (428G-->A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections. JVirol 2005, 79(24):15351-15355.
15. Kindberg E., Akerlind B., Johnsen C., Knudsen J.D., Heltberg O., Larson G., et al. Host genetic resistance to symptomatic norovirus (GGII.4) infections in Denmark. JClin Microbiol 2007, 45(8):2720-2722.
16. Rydell G.E., Kindberg E., Larson G., Svensson L. Susceptibility to winter vomiting disease: a sweet matter. Rev Med Virol 2011, 21(6):370-382.
17. Van Trang N., Vu H.T., Le N.T., Huang P., Jiang X., Anh D.D. Association between norovirus and rotavirus infection and histo-blood group antigen types in Vietnamese children. JClin Microbiol 2014, 52(5):1366-1374.
18. Ruvoen-Clouet N., Magalhaes A., Marcos-Silva L., Breiman A., Figueiredo C., David L., et al. Increase in genogroup II.4 norovirus host spectrum by CagA-positive Helicobacter pylori infection. JInfect Dis 2014, 210(2):183-191.
19. Jones M.K., Watanabe M., Zhu S., Graves C.L., Keyes L.R., Grau K.R., et al. Enteric bacteria promote human and mouse norovirus infection of B cells. Science 2014, 346(6210):755-759.
20. Skraber S., Langlet J., Kremer J.R., Mossong J., De Landtsheer S., Even J., et al. Concentration and diversity of noroviruses detected in Luxembourg wastewaters in 2008-2009. Appl Environ Microbiol 2011, 77(15):5566-5568.
21. Koo H.L., Neill F.H., Estes M.K., Munoz F.M., Cameron A., Dupont H.L., et al. Noroviruses: the most common pediatric viral enteric pathogen at a large university hospital after introduction of rotavirus vaccination. JPediatr Infect Dis Soc 2013, 2(1):57-60.
22. Vinje J., Koopmans M.P. Molecular detection and epidemiology of small round-structured viruses in outbreaks of gastroenteritis in the Netherlands. JInfect Dis 1996, 174(3):610-615.
23. Kojima S., Kageyama T., Fukushi S., Hoshino F.B., Shinohara M., Uchida K., et al. Genogroup-specific PCR primers for detection of Norwalk-like viruses. JVirol Methods 2002, 100(1-2):107-114.
24. Tamura K., Peterson D., Peterson N., Stecher G., Nei M., Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011, 28(10):2731-2739.
25. Kamel A.H., Ali M.A., El-Nady H.G., de Rougemont A., Pothier P., Belliot G. Predominance and circulation of enteric viruses in the region of Greater Cairo, Egypt. JClin Microbiol 2009, 47(4):1037-1045.
26. Belliot G., Noel J.S., Li J.F., Seto Y., Humphrey C.D., Ando T., et al. Characterization of capsid genes, expressed in the baculovirus system, of three new genetically distinct strains of 'Norwalk-like viruses'. JClin Microbiol 2001, 39(12):4288-4295.
27. de Rougemont A., Ruvoen-Clouet N., Simon B., Estienney M., Elie-Caille C., Aho S., et al. Qualitative and quantitative analysis of the binding of GII.4 norovirus variants onto human blood group antigens. JVirol 2011, 85(9):4057-4070.
28. Imbert-Marcille B.M., Barbe L., Dupe M., Le Moullac-Vaidye B., Besse B., Peltier C., et al. AFUT2 gene common polymorphism determines resistance to rotavirus A of the P[8] genotype. JInfect Dis 2014, 209(8):1227-1230.
29. Mehta C.R., Patel N.R. Exact logistic regression: theory and examples. Stat Med 1995, 14(19):2143-2160.
30. Vach W. Regression models as a tool in medical research 2013, CRC Press, Taylor and Francis Group, Boca Raton FL.
31. Mahar J.E., Bok K., Green K.Y., Kirkwood C.D. The importance of intergenic recombination in norovirus GII.3 evolution. JVirol 2013, 87(7):3687-3698.
32. Hassine-Zaafrane M., Sdiri-Loulizi K., Kaplon J., Salem I.B., Pothier P., Aouni M., et al. Prevalence and genetic diversity of norovirus infection in Tunisian children (2007-2010). JMed Virol 2013, 85(6):1100-1110.
33. Boon D., Mahar J.E., Abente E.J., Kirkwood C.D., Purcell R.H., Kapikian A.Z., et al. Comparative evolution of GII.3 and GII.4 norovirus over a 31-year period. JVirol 2011, 85(17):8656-8666.
34. Tan M., Jin M., Xie H., Duan Z., Jiang X., Fang Z. Outbreak studies of a GII-3 and a GII-4 norovirus revealed an association between HBGA phenotypes and viral infection. JMed Virol 2008, 80(7):1296-1301.
35. Carlsson B., Kindberg E., Buesa J., Rydell G.E., Lidon M.F., Montava R., et al. The G428A nonsense mutation in FUT2 provides strong but not absolute protection against symptomatic GII.4 norovirus infection. PLoS One 2009, 4(5):e5593.
36. Rydell G.E., Nilsson J., Rodriguez-Diaz J., Ruvoen-Clouet N., Svensson L., Le Pendu J., et al. Human noroviruses recognize sialyl Lewis x neoglycoprotein. Glycobiology 2009, 19(3):309-320.
37. Shirato H., Ogawa S., Ito H., Sato T., Kameyama A., Narimatsu H., et al. Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding. JVirol 2008, 82(21):10756-10767.
38. Larson G., Watsfeldt P., Falk P., Leffler H., Koprowski H. Fecal excretion of intestinal glycosphingolipids by newborns and young children. FEBS Lett 1987, 214(1):41-44.
39. Arcilla M.B., Sturgeon P. Perinatal expression of the Lewis and secretor blood group systems. Biol Neonate 1973, 22(5):407-420.
40. Procter J., Crawford J., Bunce M., Welsh K.I. Arapid molecular method (polymerase chain reaction with sequence-specific primers) to genotype for ABO blood group and secretor status and its potential for organ transplants. Tissue Antigens 1997, 50(5):475-483.